Browsing: HIV/AIDS

Summary A 60-year-old male in Manitoba, Canada, was diagnosed with Powassan virus after being bitten by a black-legged tick. The…

Global study reveals disparities in activity limitations and assistive device use among low- and middle-income countries compared to high-income countries.…

Exploratory analysis links abacavir use to increased cardiovascular risk in HIV patients. Study findings will be presented at the 2024…

Long-acting injectable cabotegravir for HIV prevention deemed safe during pregnancy in global study among cisgender women. Long-acting injectable cabotegravir (CAB-LA)…

Global progress in combating HIV/AIDS has been hindered by funding shortages, rising new infections, and gender disparities according to a…

New HIV drug Lenacapavir could be manufactured for as little as $40, potentially revolutionizing HIV treatment. A new HIV drug,…

Researchers have identified how the COVID-19 virus causes cell death in airway cells, shedding light on disease severity and potential…

UNAIDS chief urges Gilead to expand access to groundbreaking HIV drug to end pandemic. Byanyima emphasizes potential impact and benefits.…

UN warns that political decisions in 2024 will impact the global goal to end AIDS by 2030, despite progress made…

New studies suggest that daily antibiotic use could prevent STDs in high-risk groups, providing a promising solution. Popping the antibiotic…